组织学分级对滤泡性淋巴瘤结局的影响:在疾病分类和治疗演变背景下对SEER数据库患者的分析
该研究基于SEER数据库1992-2018年33 925例淋巴结滤泡性淋巴瘤(FL)患者,分析组织学分级与疾病特异性生存(DSS)和总生存(OS)的关系。结果显示FL 3级患者的DSS和OS均低于FL 1-2级,调整分期和年龄后FL 3级死亡风险仍更高。作者认为FL分级是疾病生物学的重要决定因素。
要点
- SEER数据库33 925例淋巴结FL患者中,FL 3级患者的DSS和OS均低于FL 1-2级。
- 1992-2005年FL 3级与1-2级的10年DSS分别为68.6%和71.4%,2006-2018年分别为77.7%和82.6%。
- 调整分期和年龄后,2006-2018年FL 3级较1-2级的FL特异性死亡HR为1.34(1.22-1.45)。
核心结论
- FL分级是疾病生物学的重要决定因素,FL 3级患者的DSS和OS均低于FL 1-2级。
研究设计与样本
- 基于SEER数据库的队列分析,纳入1992-2018年33 925例淋巴结FL患者,比较不同组织学分级与DSS和OS的关系。
主要发现
- 1992-2005年FL 3级与1-2级的10年DSS分别为68.6%和71.4%,2006-2018年分别为77.7%和82.6%。
- 1992-2005年FL 3级与1-2级的10年OS分别为49.9%和54.2%,2006-2018年分别为59.1%和63.5%。
- 调整分期和年龄后,1992-2005年FL 3级较1-2级的FL特异性死亡HR为1.09(1.02-1.16),全因死亡HR为1.07(1.02-1.12)。
- 调整分期和年龄后,2006-2018年FL 3级较1-2级的FL特异性死亡HR为1.34(1.22-1.45),全因死亡HR为1.16(1.10-1.23)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Currently, there is no convincing evidence that the grade of follicular lymphoma (FL) impacts patient outcome. We correlated grades in 33 925 patients with nodal FL during 1992-2018 in the SEER database with disease-specific survival (DSS) and overall survival (OS). Patients with FL grade 3 had lower DSS and OS as compared to FL grades 1-2. During 1992-2005, the 10-year DSS for patients with FL grades 3 and grades 1-2 were 68.6%, and 71.4%, respectively, and in 2006-2018, they were 77.7% and 82.6%, respectively. The 10-year OS estimates in 1992-2005 were 49.9% and 54.2% for grade 3 and grades 1-2 respectively, and in 2006-2018, they were 59.1% and 63.5% for grade 3 and grades 1-2, respectively. After adjustment for stage and age, the hazard ratios for death due to FL and death from any cause for patients with FL grade 3 during 1992-2005 were 1.09 (1.02-1.16) and 1.07 (1.02-1.12), respectively, compared to FL grades 1-2; and during 2006-2018, the hazard ratios for death due to FL and death from any cause for patients with FL grade 3 were 1.34 (1.22-1.45) and 1.16 (1.10-1.23), respectively compared to FL grades 1-2. The grade of FL is an important determinant of disease biology.
引用
- Naik A, Gooley T, Loeb K, et al. The impact of histological grade on outcomes in follicular lymphoma: An analysis of patients in the SEER database in the context of evolving disease classification and treatment. Br J Haematol. 2022. PMID: 35973829. doi:10.1111/bjh.18404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。